Nanoparticles & Nanotechnology : Clinical, Toxicological, Social, Regulatory & other aspects of Nanotechnology
In last few decades, there has been a considerable research interest in the area of drug delivery using particulate delivery systems as carriers for small and large molecules like nanoparticles. The continuing advancement of nanotechnology represents a tremendous opportunities of society because of the unique traits that nanoscale material possess but there are many clinical, toxicological, social, regulatory and other aspects of nanotechnology which are matter of concern. The United States Food and Drug Administration (FDA) and some other authorities ensures that the nanoparticle based products meet the regulatory standards for approval but like other new technologies there are many ethical issues and regulatory challenges associated with the products of nanotechnology. Before nanotechnology is largely used to enhance the quality ofÂ life, it must be made certain that health risks are taken in to the consideration, social and ethical issues are addressed,Â public opinions are gathered, and regulatory matters are assessed from all aspects.
Keywords: nanoparticles, nanotechnology, FDA, ethical issues, regulatory challenges.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).